The global contrast enhanced ultrasound market size was valued at USD 1.95 Billion in 2022 and is expected to reach USD 2.82 Billion by 2031, expanding at a CAGR of 4.2% during the forecast period, 2023-2031.
Factors such as introduction of cost-effective contrast agents, increasing demand for contrast imaging modes in ultrasound systems, and increasing ultrasound procedure volume for diagnosis of various diseases is anticipated to boost the market.
Contrast-enhanced ultrasound is defined as a technique that employs specialized imaging techniques and microbubble contrast agents. The technique is used to represent information regarding tissue perfusion and blood flow.
CEUS is safe and is performed easily. The technique does not require ionizing radiation and has no risk of nephrotoxicity. Contrast enhanced ultrasound is abbreviated as CEUS. CEUS is more radiation-free, cost-efficient, and patient-friendly as compared to other technologies. These factors are expected to propel the market.
Contrast enhanced ultrasound is employed, due to the advantages offered such as early diagnosis of COVID-19-related pneumonia. Rapid rise in the number of ultrasonography procedures related to lungs is expected to boost the demand for this process, which in turn, is projected to drive the market. Moreover, the rising incidence of gastrointestinal and cardiovascular diseases is estimated to boost the demand for contrast enhanced ultrasound in the near future.
The emergence of COVID-19 has positively affected the market, owing to the involvement of contrast enhanced ultrasound in one of the preferred grading systems for assessment of lung deterioration in COVID-19 patients. CEUS aids in identification of lung damage during the asymptomatic phase of the COVID-19.
Moreover, it is used as a bedside imaging tool to measure perfusion impairment in kidney, lung, and brain of pediatric COVID-19 patients. Considerable number of studies to detect the presence of microthrombi in COVID-19 patients is anticipated to increase the applications of CEUS and boost the usage of these devices in the near future.
Contrast Enhanced Ultrasound Market Trends, Drivers, Restraints, and Opportunities
- Contrast enhanced ultrasound is used for imaging blood perfusion in organs, which drives the market.
- Applications such as measurement of blood flow rate in the heart and other organs is anticipated to boost the market in the near future.
- Supply chain disruptions and stringent protocols such as 50% capacity in facilities is projected to hamper the market growth.
- Technological advancements and innovations are anticipated to create lucrative opportunities for the players in the market.
Scope of Contrast Enhanced Ultrasound Market Report
The report on the global contrast enhanced ultrasound market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Contrast Enhanced Ultrasound Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016-2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Equipment and Contrast Agent), Types (Non-targeted and Targeted), End-users (Hospitals, Clinics, Ambulatory Diagnostic Centers)
|
|
Regional Scope
|
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
|
|
Key Players Covered in the Report
|
Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals
|
Contrast Enhanced Ultrasound Market Segment Insights
Products Segment Analysis
Based on products, the market is bifurcated into equipment and contrast agent. The contrast agent segment is anticipated to grow at a rapid pace, owing to its adoption and rising demand. The introduction of advanced ultrasound units with transducer technology and nonlinear imaging techniques simplified the workflow of CEUS, thereby fueling the segmental share for equipment.
Types Segment Analysis
On the basis of types, the market is categorized into non-targeted and targeted. The ultrasound contrast agents used in contrast enhanced ultrasound are non-targeted. They are mostly employed to enhance diagnostic sensitivity and precision for determination of the blood volume and flow to help in differentiation between benign liver tumors and malignant. The non-targeted contrast agent segment is anticipated to hold the largest market share in 2020, owing to availability of commercial products of this type.
End-Users Segment Analysis
In terms of end-users, the market is fragmented into hospitals, clinics, and ambulatory diagnostic centers. The ambulatory diagnostic centers segment is expected to hold a large share of the market during the forecast period, owing to emergency services offered during COVID-19.
Regional Analysis
Based on regions, the contrast enhanced ultrasound market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to register substantial CAGR during the forecast period. Growth of the market in the region is attributed to research and development activities in contrast enhanced ultrasound in North America.
Segments
Products
Types
End-Users
- Hospitals
- Clinics
- Ambulatory Diagnostic Centers
Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
Competitive Landscape
Key players in the market include Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals among others. These companies are considered as key players in the global contrast enhanced ultrasound market based on their revenue, product offerings, and supply chain management system.
Players are adopting key strategies such as acquisition, collaborations, and geographical expansion to make use of potential opportunities in the global contrast enhanced ultrasound market.
Request For Customization
Enquiry Before Buying
Speak With Analyst
